6.7 C
Saturday, April 10, 2021

Mubadala Health Obesity Management Center Achieves European Accreditation for Its Abu Dhabi Unit

Must read

UK Time Newshttps://www.uktimenews.com
UK Time News is your daily dose of Latest News, Entertainment, Music, Fashion, Lifestyle, World, Cricket, Sports, Politics, Tech, Business News Website. We provide you with the Latest Breaking News Straight from the UK & all around the World on different categories.

EASO’s Obesity Management Working Group completed its assessment of ICLDC in Abu Dhabi and granted it a COM status of initial two-year international affiliation with EASO from April 1 of this year.
Image Credit: Courtesy: Mubadala

Abu Dhabi: Mubadala Health’s Imperial College London Diabetes Center (ICLDC) became the first such facility in Abu Dhabi and the third in the UAE to be accredited as a Collaborating Center for the Management of Obesity (COM) by the European Association for the Study of Obesity (EASO).

Under the EASO COM program, obesity management centers are accredited according to a set of strict criteria and in accordance with accepted European and university guidelines to ensure consistently high standards in different countries around the world.

EASO’s Obesity Management Working Group completed its assessment of ICLDC and granted it COM status of initial two-year international affiliation with EASO effective April 1 of this year. . In addition, the organization recognized two of ICLDC’s experts – Dr Mohgah El Sheikh and Dr Matthew Allum, both endocrinologists and consultant diabetologists – as EASO National Clinical Fellows.

Dr Alya Al Mazrouei, Interim Executive Director of ICLDC, said: “We are delighted to have received this recognition, which confirms our expertise in managing obesity alongside diabetes. In addition, the goal of Mubadala Health and the ICLDC is to provide world-class services to the UAE and the region, and this successful assessment of our standards and experts by the EASO working group proves that we are doing it.

Risk of developing type 2 diabetes

Dr El Sheikh, who is also the ICLDC’s clinical leader for obesity and metabolic surgery, said: “Obesity is thought to represent 80-85% of the risk of developing type 2 diabetes. , while research suggests that obese people can more than halve their risk of developing type 2 diabetes by losing 5-10% of their body weight. “

Dr Al Mazrouei added that in addition to treating obesity through dietary approaches, medication and treatment of underlying conditions, the ICLDC also works closely with his colleague’s bariatric surgeons. Mubadala partner, Healthpoint, which is accredited as a center of excellence by another international. body, the Surgical Review Corporation.

Among these international accreditations, Dr Al Mazrouei explained: “Obesity is a global epidemic with serious health, economic and social consequences. It is therefore important that countries work together and share their knowledge to ensure that a consistent and optimal approach is taken. As such, it is important that the ICLDC works with organizations such as EASO and the World Obesity Federation on projects that include international awareness and the formulation of guidelines to combat obesity. “

Dr El Sheikh added that as a member of the EASO COM network, ICLDC will also have the opportunity to assist the network in its goal of developing consensus guidelines on several issues of management of the obesity.

More articles


Please enter your comment!
Please enter your name here


Latest article